Zydus receives final approval from USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The inspection was a cGMP Inspection and had ended with NIL observations
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Subscribe To Our Newsletter & Stay Updated